BioSpace News Archive

The measles, mumps, and rubella vaccines market is observing significant growth due to high incidence of pneumococcal infections.

The patient engagement solutions market is predicted to expand at a stellar growth rate over the forecast period from 2020 to 2030.

Lacutamab received PRIME designation from the European Medicines Agency in Sezary Syndrome; clinical development program advances in mycosis fungoides and peripheral T-cell lymphoma

ITM AG, a privately held radiopharmaceutical biotech company, announced that is has signed two strategic agreements with Telix Pharmaceuticals Limited for the global supply of ITM’s highly pure therapeutic radioisotope no-carrier-added Lutetium-177.

PureTech Health plc, a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, announces that Stephen Muniz, Esq., will retire from his role as Chief Operating Officer and Corporate Secretary and will step down from the Board Of Directors, effective May 17, 2021.

SpeeDx have announced signing a new distribution partner, further extending customer access to market-leading SpeeDx ResistancePlus® and PlexPCR® tests.

Based on very strong order intake during the first 10 weeks of 2021 and high demand expected to continue in the further course of the year, Sartorius Stedim Biotech has raised its growth forecast for fiscal 2021.

License with NIH for intellectual property for a clinically-validated, GMP grade feeder cell line to enable robust natural killer (NK) cell expansion

XPhyto Therapeutics Corp., and its exclusive German diagnostics development partner, 3a-diagnostics GmbH, are pleased to announce the European approval of its point-of-care SARS-CoV-2 RT-PCR test system.

Long-term care homes have been at the epicentre of the COVID-19 pandemic in Canada, with 70 percent of COVID-19 deaths having occurred in long-term care or nursing homes.